📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention (2020)

First Author: Turner R

Attributed to: MICA: Applying innovative technologies to improve benefit-risk ratio of drugs: developing a national resource underpinned by the MRC Centre for CDSS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14133

PubMed Identifier: 31656041

Publication URI: http://europepmc.org/abstract/MED/31656041

Type: Journal Article/Review

Parent Publication: British Journal of Clinical Pharmacology

Issue: 1

ISSN: 0306-5251